Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio Warns It Needs Cash to Continue Operations Beyond September

NEW YORK (GenomeWeb News) – Pressure BioSciences said in its quarterly earnings document that it may not be able to fund its operations beyond next month.

In its Form 10-Q filed with the US Securities and Exchange Commission on Thursday, the South Easton, Mass.-based company said that as of June 30, it had $113,663 in cash and cash equivalents and warned that it will need "substantial additional capital" to fund operations beyond the end of September 2013.

"In the event that we are unable to obtain financing on acceptable terms, or at all, we will likely be required to cease our operations, pursue a plan to sell our operating assets, or otherwise modify our business strategy, which could materially harm our future business prospects," it said.

On Thursday, the company reported a 10 percent increase in revenues for its second quarter. However, Pressure Bio has been under financial pressure for a while now. In May, it warned of similar cash problems, saying at the time it might not be able to maintain operations beyond May.

In its 10-Q, Pressure Bio said that it signed agreements to borrow a total of $875,000 from three lenders in April through June. Through Aug. 1, it received $542,500 under the agreements, though "[t]here is no guaranty that the company will receive the amounts remaining under these agreements."

Pressure Bio added that last week it received $160,000 in a one-year note from an existing shareholder. Terms of that note included "18 percent annual interest, one three-year warrant to acquire 160,000 shares of common stock at $0.40 per share, and a right to convert the note into the next equity financing."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.